Navigation Links
Seahorse Bioscience Receives Poster Award from the European Association for the Study of Obesity
Date:7/18/2008

Mechanism of Action of Metformin on Insulin Sensitization Poster Wins One

of Three Prizes

N. BILLERICA, Mass., July 18 /PRNewswire/ -- Seahorse Bioscience, Inc., leaders in real-time measurement of cellular bioenergetics announced today the receipt of The European Association for the Study of Obesity (EASO) poster award at the 16th European Congress on Obesity (ECO 2008) May 14-17, 2008 in Geneva, Switzerland.

The poster, Mechanism of Action of Metformin on Insulin Sensitization: Selective Fatty Acid Oxidation (FAO) over Glucose Oxidation via Inhibition of Complex I and Activation of AMP-activated protein kinase in C2C12 myocytes presented by author Dr. Min Wu of Seahorse Bioscience, was one of three posters to win the prestigious 2008 EASO Poster Prize. Poster Prize winners have already been listed on the EASO website (http://www.easoobesity.org) and will be highlighted in the Association's next e-newsletter.

"We are very pleased that EASO recognized our work on cellular mechanism of action of metformin," said David Ferrick, Vice President of Biology. "It is the bioenergetic analysis of fuel substrate selections that revealed the mechanism of action in different cell types, an analysis with the potential to be very powerful in the understanding and treatment of many other age-related diseases."

"It is unusual for an instrument manufacturer to be recognized for scientific contribution but Seahorse XF technology enables novel discoveries by bringing to light the importance of energy producing pathways of the cell," said Steven Chomicz, Vice President of Sales and Marketing for Seahorse Bioscience. "Dr. Wu used the features of the XF24 extracellular flux analyzer to perform an eloquent experiment which revealed metformin's, heretofore, unknown mechanism of action. This potential for award winning discoveries is why Seahorse XF technology is used by leading bioenergetic labs worldwide."

About Seahorse Bioscience, Inc.

Seahorse Bioscience is changing cancer, obesity, diabetes and age-related drug discovery programs the world over. Seahorse headquarters are located in North Billerica, Massachusetts. For more information, please visit http://www.seahorsebio.com.

If you would like more information about Seahorse Bioscience, Inc., or would like to schedule a meeting with Steve Chomicz, please contact Kristine Hunt at 978-671-1610.

Seahorse Bioscience, Inc.

Media Contact: Kristine Hunt

Phone: 978-671-1610


'/>"/>
SOURCE Seahorse Bioscience, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
4. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
7. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
9. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
10. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ca (PRWEB) , ... October 12, 2017 , ... ... the Surgical Wound Market with the addition of its newest module, US Hemostats ... $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic ...
(Date:10/11/2017)... ... ... eye wash is a basic first aid supply for any work environment, but most personal ... rinse first if a dangerous substance enters both eyes? It’s one less decision, and likely ... dual eye piece. , “Whether its dirt and debris, or an acid or alkali, getting ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions ... over 5.5 million people each year. Especially those living in larger cities are affected ... based in one of the most pollution-affected countries globally - decided to take action. ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global eye tracking market to grow at a CAGR ... Global Eye Tracking Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
Breaking Biology News(10 mins):